BDWM
BTAI icon

Brewin Dolphin Wealth Management’s BioXcel Therapeutics BTAI Stock Holding History

Brewin Dolphin Wealth Management’s Portfolio BTAI Stock Details BTAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-125
Closed -$86.3K – 340
2021
Q1 		$86.3K Buy
+125
New +$86.3K 0.01% 148